Andrew F. Wilks

机构：Boston University, Boston Medical Center · ORCID：0000-0002-8554-2399

发表论文 129 篇 · 总被引 11544 次 · h-index 49

代表论文

• Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) (1998 · Proceedings of the National Academy of Sciences · 被引 1215)
• Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death (2014 · Proceedings of the National Academy of Sciences · 被引 612)
• Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond (2016 · PLoS Pathogens · 被引 453)
• Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains (2009 · Journal of Molecular Biology · 被引 275)
• The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor (2005 · Blood · 被引 269)
• Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk (2000 · Nature Genetics · 被引 173)